Statins and Cognitive Impairment: Mechanisms, Evidence, and Research Directions
Author:
Open Access
- 28 November 2025
- journal article
- Published by Neuroscience Therapeutics and Trials Association in NeuroTrials
- Vol. 1 (1) , 21-29
Abstract
Han-Jin Cho. NeuroTrials 2025;1:11-6. https://doi.org/10.65321/ntta.2025.003Keywords
This publication has 17 references indexed in Scilit:
- Statin use and dementia risk: A systematic review and updated meta‐analysisAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2025
- Pragmatic evaluation of events and benefits of lipid lowering in older adults ( PREVENTABLE ): Trial design and rationaleJournal of the American Geriatrics Society, 2023
- Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive FunctionJACC, 2022
- Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older AdultsJACC, 2021
- Pravastatin and cognitive function in the elderly. Results of the PROSPER studyJournal of Neurology, 2009
- Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam StudyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Immunomodulation by statins: Inhibition of cholesterol vs. isoprenoid biosynthesisBiomedicine & Pharmacotherapy, 2007
- Atorvastatin for the Treatment of Mild to Moderate Alzheimer DiseaseArchives of Neurology, 2005
- Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adultsThe American Journal of Medicine, 2004
- Isoprenoid metabolism and the pleiotropic effects of statinsCurrent Atherosclerosis Reports, 2003